Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 5:20 PM View:  | Moulder Leon O Jr Chief Executive Officer Director | Zenas Biopharma, Inc. (ZBIO) | 19-Nov-24 | Purchase | 2,500 | $14.57 | $36,425.00 | < 1% 1.84M to 1.84M | |
| 20-Nov-24 5:20 PM View: | Moulder Leon O Jr Chief Executive Officer Director | Zenas Biopharma, Inc. (ZBIO) | 18-Nov-24 | Private Purchase | 7,500 | $15.00 | $112,500.00 | < 1% 1.83M to 1.84M | |
| 20-Sep-24 6:34 PM View: | Moulder Leon O Jr Chief Executive Officer Director | Zenas Biopharma, Inc. (ZBIO) | 20-Sep-24 | Market Purchase | 5,000 | $18.45 | $92,270.00 | < 1% 1.83M to 1.83M | (5%) |
| 20-Sep-24 6:34 PM View: | Moulder Leon O Jr Chief Executive Officer Director | Zenas Biopharma, Inc. (ZBIO) | 19-Sep-24 | Market Purchase | 5,000 | $17.89 | $89,450.00 | < 1% 1.82M to 1.83M | (2%) |
| 20-Sep-24 6:34 PM View: | Moulder Leon O Jr Chief Executive Officer Director | Zenas Biopharma, Inc. (ZBIO) | 18-Sep-24 | Market Purchase | 10,000 | $17.91 | $179,100.00 | < 1% 1.81M to 1.82M | (2%) |
| 18-Sep-24 4:15 PM View: | Enavate Sciences Gp, LLC 10% Owner | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Conversion | 2,879,010 | -- | -- | 100% 0 to 2.88M | |
| 16-Sep-24 8:54 PM View: | Nunn Jason Raleigh Director | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Market Purchase | 882,352 | $17.00 | $15,000,000.00 | 41% 2.17M to 3.06M | |
| 18-Sep-24 4:15 PM View: | Enavate Sciences Gp, LLC 10% Owner | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Market Purchase | 882,353 | $17.00 | $15,000,000.00 | 31% 2.88M to 3.76M | |
| 16-Sep-24 8:46 PM View: | Moulder Leon O Jr Chief Executive Officer Director | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Conversion | 372,017 | -- | -- | 136% 272.9K to 644.92K | |
| 16-Sep-24 8:54 PM View: | Nunn Jason Raleigh Director | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Conversion | 2,174,450 | -- | -- | 100% 0 to 2.17M | |
| 18-Sep-24 5:16 PM View: | Wellington Biomedical Innov... 10% Owner | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Conversion | 801,624 | -- | -- | 100% 0 to 801.62K | |
| 16-Sep-24 8:57 PM View: | Enright Patrick G Director | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Market Purchase | 440,000 | $17.00 | $7,480,000.00 | 132% 334.53K to 774.53K | |
| 16-Sep-24 8:46 PM View: | Moulder Leon O Jr Chief Executive Officer Director | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Conversion | 164,523 | -- | -- | 100% 0 to 164.52K | |
| 16-Sep-24 8:46 PM View: | Moulder Leon O Jr Chief Executive Officer Director | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Conversion | 48,254 | -- | -- | 7% 644.92K to 693.17K | |
| 16-Sep-24 10:00 PM View: | Fairmount Funds Management ... Director | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Conversion | 1,304,890 | -- | -- | 100% 0 to 1.3M | |
| 16-Sep-24 8:51 PM View: | Sr One Capital Management, ... 10% Owner | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Market Purchase | 2,235,290 | $17.00 | $38,000,000.00 | 84% 2.68M to 4.91M | |
| 16-Sep-24 10:00 PM View: | Fairmount Funds Management ... Director | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Market Purchase | 300,000 | $17.00 | $5,100,000.00 | 23% 1.3M to 1.6M | |
| 16-Sep-24 8:46 PM View: | Moulder Leon O Jr Chief Executive Officer Director | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Conversion | 108,381 | -- | -- | 66% 164.52K to 272.9K | |
| 16-Sep-24 8:51 PM View: | Sr One Capital Management, ... 10% Owner | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Conversion | 2,676,240 | -- | -- | 100% 0 to 2.68M | |
| 17-Sep-24 7:52 PM View: | Lu Hongbo Director | Zenas Biopharma, Inc. (ZBIO) | 13-Sep-24 | Purchase | 58,823 | $17.00 | $999,991.00 | 100% 0 to 58.82K |
